Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion

On February 23, 2026, CNBC reported that Gilead Sciences announced it would get Arcellx, Inc. (NASDAQ:ACLX) for up to $7.8 cardinal to grow its crab attraction pipeline. The corp agreed to wage $115 per stock successful cash, a 79% premium implicit Arcellx, Inc. (NASDAQ:ACLX)’s past closing price. Its banal jumped 77.9% to $114.06 successful greeting trading. The woody is Gilead's largest since its acquisition of Immunomedics for $21 cardinal successful 2020. Gilead Sciences CEO Daniel O'Day has explored acquisitions and partnerships arsenic the steadfast aims to grow beyond HIV and liver illness therapies, notwithstanding declining revenues from its flagship COVID-19 medicine, Veklury, and imaginable patent losses.

The acquisition boosts Gilead's presumption successful compartment therapy with anito-cel, an investigational CAR-T attraction for aggregate myeloma developed by Kite Pharma and Arcellx, Inc. (NASDAQ:ACLX). The U.S. Food and Drug Administration is considering the therapy arsenic a fourth-line treatment, with a determination acceptable for December 23, 2026. According to Brian Abrahams of RBC Capital Markets, the attraction whitethorn person a amended information illustration than Carvykti, which was developed by Johnson & Johnson and Legend Biotech. Gilead anticipates the transaction to beryllium completed successful the 2nd 4th of 2026.

Arcellx, Inc. (NASDAQ:ACLX) is simply a clinical-stage biotechnology concern that develops caller immunotherapies for crab and different incurable diseases.

While we admit the imaginable of ACLX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Best Electric Utility Stocks to Invest In Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.

Disclosure: None. Follow Insider Monkey connected Google News.